Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning

How can small biotechs tap billion‑dollar AI models without giving up their data? David Wild talks with Eli Lilly's Aliza Apple about Lilly TuneLab, a federated learning platform that lets companies use Lilly’s in-house drug discovery models while keeping their IP and datasets fully private. They dive into early use cases in ADMET and antibody developability, what early-stage users actually do in their first 90 days, and how shared models could reshape the economics of drug R&D.